Join to view full profile
9500 Euclid AveCleveland, OH 44195
Phone+1 800-223-2273
Dr. Ransohoff is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Cleveland Clinic FoundationResidency, Neurology, 1981 - 1982
The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 1978 - 1980
Case Western Reserve University School of MedicineClass of 1978
Certifications & Licensure
OH State Medical License 1979 - 2016
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Publications & Presentations
PubMed
- 15 citationsA transcriptomic microglia taxonomy across mouse and human pathologies.Chintan Chhatbar, Roman Sankowski, Michael Schulz, Takashi Shimizu, Marius Schwabenland
Nature Immunology. 2026-05-01 - 1 citationsFocused ultrasound-enhanced cell therapy for brain tumors: Summary of roundtable discussions.Frederic Padilla, Costas Arvanitis, Catherine M Bollard, Marco Gallus, John De Groot
Neuro-Oncology Advances. 2026-02-14 - 484 citationsNeuroinflammation in Alzheimer disease.Michael T Heneka, Wiesje M van der Flier, Frank Jessen, Jeroen Hoozemanns, Dietmar Rudolf Thal
Nature Reviews. Immunology. 2025-05-01
Press Mentions
Microglia as Therapeutic Targets in Neurodegenerative DiseasesOctober 1st, 2021- Abata Hopes to Find ‘Perfect Fit’ with MS Cell Therapy After $95M Series AJune 23rd, 2021
- Third Rock-Backed Startup Launches to Develop Cell Therapies for MS, DiabetesJune 23rd, 2021
Grant Support
- The Role Of Fractalkine Signaling In Neurodegenerative DiseaseNational Institute Of Neurological Disorders And Stroke2011–2012
- Modulating Chemokine Receptors At The Blood-Brain Barrier Under FlowNational Institute Of Neurological Disorders And Stroke2011–2012
- Tissue Acquisition, Imaging, Biostatistics, Administration CoreNational Institute Of Neurological Disorders And Stroke2010–2012
- Cortical Demyelination Early In MSNational Institute Of Neurological Disorders And Stroke2010–2012
- Chemokines In CNS InflammationNational Institute Of Neurological Disorders And Stroke2004–2012
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
